Greg Yap

Background

Greg Yap is a Partner at Menlo Ventures (joined 2017) leading life science and healthcare investments. He co-founded BlueLight Therapeutics and PyrAmes, and previously led a $500M annual cancer diagnostic business at Roche Diagnostics/Ventana. He holds a BS in Molecular Biology summa cum laude from Princeton and an MBA from Stanford GSB.

Investment Focus

Notable Investments

Xaira Therapeutics

AI drug discovery

Benchling

Life sciences R&D platform

Delfi Diagnostics

Liquid biopsy cancer detection

Encoded Therapeutics

Gene therapy platform